PRIVATE
Cannabis has been used for therapeutic purposes for more than 4,000 years.
Multiple studies have been conducted worldwide, investigating and highlighting the numerous medicinal benefits of this plant. Within professional medical fields, the treatment for illnesses with cannabis derivatives has spread.
Investor exclusive access to Grüne Labs Financial Data Reports
The innovative merit of the project is the obtainment of cannabis oils, which contain a sought-after cannabinoids mix for the treatment of various diseases, through a combination of proper procedures for seed selection, plant production and standardized extraction processes.
COMERCIAL JUSTIFICATION
The medicinal use of cannabis is an issue currently on the agenda for most countries in the world. Latin America is no exception, as governments in the region debate the legalization of the production and the specific uses of the plant.
By February 2018, medicinal use was regulated and permitted for most countries in the region. But there are still hundreds of cases where Cannabis extracts are imported for compassionate medicinal use.
Currently, cannabis extracts with the characteristics produced by Grüne Labs are not available in the local and regional market, nor are the production processes that ensure Pharma-Grade level quality.
GrüneLabs is a global biopharmaceutical company with operations in Uruguay, and Portugal.
+598 2291 4543
- Uruguay
Departamento de Canelones
- Portugal
Parque Industrial Gardunha Sul
6005-300 | Soalheira
Castelo Branco
